IP Library › Patent Application 11352275
Patent Application
App. No. 11/352,275

TNF receptor and steroid hormone in a combined therapy

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/352,275
Abstract

The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1, together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.

Claims (3)

1 . A method for treating lethal virus infections in a patient which comprises administering to a patient a tumor necrosis factor (TNF) receptor in combination with dehydroepiandrosterone (DHEA) simultaneously, separately or sequentially.

2 . The method of claim 18 , wherein the TNF receptor is TNF Binding Protein-2.

3 . The method of claim 18 , wherein the TNF receptor is TNF Binding Protein-1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →